Insilico Medicine (03696.HK), a clinical-stage biopharmaceutical company powered by generative artificial intelligence, will participate in WHX 2026 (World Health Expo 2026), taking place February 9–12, 2026 at the Dubai Exhibition Centre, UAE. As one of the leading global events for the healthcare industry, WHX 2026 will bring together international healthcare companies, research institutions, innovators, and investors to discuss key topics across biopharmaceuticals, medical devices, digital health, and life sciences—providing an efficient platform for exchange and collaboration serving the Middle East and global markets.
At WHX 2026, Insilico Medicine will exhibit jointly with its strategic partner, the Emirates Drug Establishment (EDE). The joint booth will be located at South Hall, S19J30, Emirates Health, where the company will highlight its latest progress and real-world applications in AI-driven drug discovery and development.
Dr. Alex Aliper, PhD, President of Insilico Medicine, has been invited to speak on February 9 (local time), 3:10–3:40 PM, at the “Frontiers Stage: Biotechnology & Life Sciences” forum, joining a panel titled “Translational Research and Innovation: From Regional to Global” Together with experts and industry leaders from regional research organizations and the global biotech community, the panel will explore ways to strengthen links between regional institutions and global biotech leaders, enhance translational pathways to move laboratory breakthroughs into clinical applications, and attract international capital into regional R&D ecosystems.
Since February 2023, Insilico Medicine has operated an AI and quantum computing drug discovery R&D center in Abu Dhabi. As one of the largest AI-driven drug discovery hubs in the Middle East, the center is dedicated to advancing drug discovery programs and the development of Insilico’s Pharma.AI platform, while fostering cross-disciplinary innovation at the intersection of artificial intelligence and life sciences.
The R&D center has established close and in-depth collaborations with leading UAE academic institutions, including Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), Khalifa University, New York University Abu Dhabi (NYU Abu Dhabi), and United Arab Emirates University. Through joint research initiatives, talent development programs, and academic exchange platforms, Insilico Medicine is actively contributing to the region’s innovation ecosystem and continues to generate research outcomes with global impact.
These strategic efforts underscore Insilico Medicine’s commitment to advancing scientific progress across the Middle East and beyond, strengthening leadership in AI-enabled biotechnology, and sustaining long-term investment in a diverse, international talent base and an open, collaborative innovative environment.
About World Health Expo Dubai (WHX Dubai)
World Health Expo Dubai (WHX Dubai), formerly known as Arab Health, is a global meeting place for the healthcare community dedicated to advancing healthcare worldwide. For more than 50 years, it has served as a key platform for professionals driving the industry forward. As part of one of the world’s largest international healthcare exhibition networks, WHX Dubai connects attendees with the people, products, and ideas shaping healthcare today. Over four days, thousands of professionals come together to build meaningful connections and deliver tangible outcomes.
At WHX 2026, Insilico Medicine will exhibit jointly with its strategic partner, the Emirates Drug Establishment (EDE). The joint booth will be located at South Hall, S19J30, Emirates Health, where the company will highlight its latest progress and real-world applications in AI-driven drug discovery and development.
Dr. Alex Aliper, PhD, President of Insilico Medicine, has been invited to speak on February 9 (local time), 3:10–3:40 PM, at the “Frontiers Stage: Biotechnology & Life Sciences” forum, joining a panel titled “Translational Research and Innovation: From Regional to Global” Together with experts and industry leaders from regional research organizations and the global biotech community, the panel will explore ways to strengthen links between regional institutions and global biotech leaders, enhance translational pathways to move laboratory breakthroughs into clinical applications, and attract international capital into regional R&D ecosystems.
Since February 2023, Insilico Medicine has operated an AI and quantum computing drug discovery R&D center in Abu Dhabi. As one of the largest AI-driven drug discovery hubs in the Middle East, the center is dedicated to advancing drug discovery programs and the development of Insilico’s Pharma.AI platform, while fostering cross-disciplinary innovation at the intersection of artificial intelligence and life sciences.
The R&D center has established close and in-depth collaborations with leading UAE academic institutions, including Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), Khalifa University, New York University Abu Dhabi (NYU Abu Dhabi), and United Arab Emirates University. Through joint research initiatives, talent development programs, and academic exchange platforms, Insilico Medicine is actively contributing to the region’s innovation ecosystem and continues to generate research outcomes with global impact.
These strategic efforts underscore Insilico Medicine’s commitment to advancing scientific progress across the Middle East and beyond, strengthening leadership in AI-enabled biotechnology, and sustaining long-term investment in a diverse, international talent base and an open, collaborative innovative environment.
About World Health Expo Dubai (WHX Dubai)
World Health Expo Dubai (WHX Dubai), formerly known as Arab Health, is a global meeting place for the healthcare community dedicated to advancing healthcare worldwide. For more than 50 years, it has served as a key platform for professionals driving the industry forward. As part of one of the world’s largest international healthcare exhibition networks, WHX Dubai connects attendees with the people, products, and ideas shaping healthcare today. Over four days, thousands of professionals come together to build meaningful connections and deliver tangible outcomes.